Archives: Agenda

PANEL DISCUSSION: Patient centricity in oncology trials: where are the opportunities for the industry and patients?

  • Simple ways of improving patient experience in clinical trials including vocabulary and clear communication
  • Relieving burden on caregivers as well as patients: how can sponsors be more supportive of patients’ families and support network?
  • Working with patients from the beginning of your clinical trial design process
  • Assessing new innovation and technology which can increase support and relieve pressure on oncology patients
  • Where and how can trial sponsors step in to provide long term support for rare cancer patients?

CASE STUDY: Setting up a Phase 1 oncology trial in the UK

·       Running a study in conjunction with UK sites

·       The impact of regulatory changes on running oncology studies

·       Managing and negotiating costs to stay within budget

·       How to work effectively and efficiently with sites to set up your study

Managing Human specimens and data in the current changing geopolitical and regulatory landscape

This session explores the evolving role of patient consent in clinical trials, focusing on how to maximize its value while ensuring ethical and regulatory compliance. As geopolitical and regulatory landscapes shift, the management of patient samples and data has become increasingly complex. Industry experts will discuss strategies for streamlining consent processes, enhancing transparency, and addressing the challenges of cross-border data and sample handling.

  • The changing nature of patient consent
  • Geopolitical and regulatory impacts on data management
  • Innovative approaches to sample and data tracking
  • Future trends in patient consent and data usage